US 9499818
Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene
granted A61KA61K31/56A61K31/57
Quick answer
US patent 9499818 (Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/56, A61K31/57, A61K31/573, A61K31/58